MIT agrees to accept Whitehead grant

WebWise: guide to the Stanford Human Genome Center and the Whitehead/MIT Genome Center web sites.

This installment of the WebWise series reviews two web sites: (1) the Stanford Human Genome Center (SHGC; http://www-shgc.stanford.edu/), and (2) the Whitehead/MIT Genome Center (W/MIT; http://www-genome.wi.mit. edu/). Although the overall organization and style of these two web sites are quite different, the centers share an important feature. Both sites make available a large amount of physic...

Preparation of YAC end fragments from the whitehead/MIT mouse YAC library pRML vectors.

Data Analysis Production Line : An Example from the Whitehead / MIT Center for Genomic Research

Finishing is the final phase of the gene sequencing process employed in the Human Genome Project. During the finishing process, analysts inspect and resolve ambiguous regions of DNA. While other phases of gene sequencing have evolved into high-volume, automated processes, finishing has remained manual, time-consuming, and costly. This thesis studies finishing as an example of a broader class of...

Calibration of Willingness-to-Accept

This paper calibrates real and hypothetical willingness-to-accept estimates elicited for consumer goods in a multi-unit, random nth-price auction. Using a within-subject experimental design, we find that people understated their real willingness to accept in the hypothetical regimes, framed both as demand and non-demand revealing. After controlling for personspecific effects, however, hypotheti...

Diet drug maker agrees to $3.75 billion settlement.

American Home Products, the maker of Pondim (fenfluramine) and Redux (dexfenfluramine), recently agreed to pay as much as $3.75 billion to people who took the diet drug cocktail called fen-phen or Redux, a settlement that attorneys called the largest ever involving a US pharmaceutical firm (fen-phen was a combination of fenfluramine and phentermine). The nationwide, class-action settlement is o...